Specific inhibitors that could prevent the loss of nerve cells in different mouse models of Alzheimer's disease uncovered.

Expanded agreement includes development of additional transgenic mouse technologies and performance of additional therapeutic antibody research programs FOSTER CITY, CA / ACCESSWIRE / October 31, 2024 ...

Expanded agreement includes development of additional transgenic mouse technologies and performance of additional therapeutic antibody research programs FOSTER CITY, CA / ACCESSWIRE / October 31, 2024 ...

AbTherx announced the expansion of a previous agreement with Gilead (GILD) Sciences to develop novel antibody discovery technologies and ...

A new study shows the ketogenic diet increases anti-inflammatory compounds in mouse model of multiple sclerosis.

Researchers at Cornell have unveiled an advanced imaging technology capable of unprecedented deep and wide-field ...

The ketogenic diet could help manage multiple sclerosis (MS) by promoting the production of beneficial compounds in the gut.

A new resource by Rappe et al (2024) now provides a spatiotemporal landscape of mitophagy changes during mouse brain aging at ...

Agreement provides Scripps Research scientists with broad access to Alloy’s fully human transgenic mouse platform, which has the power to increase the pace and success rate of antibody discovery and ...

Breakthrough polymer-based therapy shows promise in reversing Huntington's disease symptoms by preventing toxic protein ...

Skye Bioscience (SKYE) announced preliminary data from a diet-induced obesity model in mice. Skye’s CB1-inhibiting antibody, nimacimab, ...